Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Pagonabarraga

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Revista De Neurologia|October 28, 2010
[Rasagiline: effectiveness and protection in Parkinson's disease]Javier Pagonabarraga, Jaume Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Brief cognitive tests in the screening of dementia in Parkinson's diseaseJavier Pagonabarraga, Jaime Kulisevsky
Neurobiology of Disease|April 10, 2012
Cognitive impairment and dementia in Parkinson's diseaseJavier Pagonabarraga, Jaime Kulisevsky
Revista De Neurologia|December 18, 2013
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?]Javier Pagonabarraga, Jaume Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2009
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessmentJaime Kulisevsky, Javier Pagonabarraga
International Review of Neurobiology|August 14, 2017
Apathy in Parkinson's DiseaseJavier Pagonabarraga, Jaime Kulisevsky
Drug Safety|January 20, 2010
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsJaime Kulisevsky, Javier Pagonabarraga
Neurology and Therapy|December 4, 2024
Sex Differences in Parkinson's Disease: A Narrative ReviewCarlo Cattaneo, Javier Pagonabarraga
Revista De Neurologia|June 2, 2010
[Head tremor]Alexandre Gironell, Bàrbara Vives, Javier Pagonabarraga
Recent Patents on CNS Drug Discovery|January 20, 2009
Individual triptan selection in migraine attack therapyRobert Belvís, Javier Pagonabarraga, Jaime Kulisevsky
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Revista De Neurologia|October 28, 2010
[Rasagiline: effectiveness and protection in Parkinson's disease]Javier Pagonabarraga, Jaume Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Brief cognitive tests in the screening of dementia in Parkinson's diseaseJavier Pagonabarraga, Jaime Kulisevsky
Neurobiology of Disease|April 10, 2012
Cognitive impairment and dementia in Parkinson's diseaseJavier Pagonabarraga, Jaime Kulisevsky
Revista De Neurologia|December 18, 2013
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?]Javier Pagonabarraga, Jaume Kulisevsky
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2009
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessmentJaime Kulisevsky, Javier Pagonabarraga
International Review of Neurobiology|August 14, 2017
Apathy in Parkinson's DiseaseJavier Pagonabarraga, Jaime Kulisevsky
Drug Safety|January 20, 2010
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsJaime Kulisevsky, Javier Pagonabarraga
Neurology and Therapy|December 4, 2024
Sex Differences in Parkinson's Disease: A Narrative ReviewCarlo Cattaneo, Javier Pagonabarraga
Revista De Neurologia|June 2, 2010
[Head tremor]Alexandre Gironell, Bàrbara Vives, Javier Pagonabarraga
Recent Patents on CNS Drug Discovery|January 20, 2009
Individual triptan selection in migraine attack therapyRobert Belvís, Javier Pagonabarraga, Jaime Kulisevsky
Pageof 18